Insider Selling: Itron (NASDAQ:ITRI) SVP Sells $50,778.96 in Stock

Itron, Inc. (NASDAQ:ITRI) SVP Donald Reeves III sold 519 shares of the stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $97.84, for a total value of $50,778.96. Following the completion of the transaction, the senior vice president directly owned 29,951 shares of the company’s stock, valued at $2,930,405.84. This represents a 1.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Itron Trading Down 2.2%

NASDAQ ITRI opened at $93.95 on Monday. The firm has a market capitalization of $4.22 billion, a PE ratio of 14.43, a P/E/G ratio of 0.82 and a beta of 1.44. The stock’s 50 day moving average is $97.80 and its 200 day moving average is $108.89. Itron, Inc. has a twelve month low of $88.57 and a twelve month high of $142.00. The company has a quick ratio of 1.56, a current ratio of 1.80 and a debt-to-equity ratio of 0.45.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, beating the consensus estimate of $2.19 by $0.27. The business had revenue of $571.66 million during the quarter, compared to analyst estimates of $561.31 million. Itron had a return on equity of 20.04% and a net margin of 12.72%.The company’s revenue for the quarter was down 6.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.35 earnings per share. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Research analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on ITRI shares. Stephens raised shares of Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 target price for the company in a research note on Monday, November 3rd. Argus restated a “hold” rating on shares of Itron in a research note on Tuesday, November 4th. Weiss Ratings cut Itron from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Zacks Research raised Itron from a “strong sell” rating to a “hold” rating in a report on Thursday. Finally, Wall Street Zen cut Itron from a “buy” rating to a “hold” rating in a research note on Wednesday, January 14th. Seven equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Itron presently has a consensus rating of “Moderate Buy” and a consensus target price of $138.56.

Institutional Trading of Itron

Several institutional investors have recently added to or reduced their stakes in ITRI. EverSource Wealth Advisors LLC raised its stake in shares of Itron by 25.3% in the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after purchasing an additional 81 shares during the last quarter. Amalgamated Bank boosted its position in shares of Itron by 0.7% during the third quarter. Amalgamated Bank now owns 13,060 shares of the scientific and technical instruments company’s stock valued at $1,627,000 after buying an additional 86 shares during the last quarter. PFG Investments LLC increased its holdings in Itron by 4.8% in the 3rd quarter. PFG Investments LLC now owns 2,059 shares of the scientific and technical instruments company’s stock worth $256,000 after buying an additional 94 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in Itron by 29.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock worth $41,000 after buying an additional 101 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC raised its position in Itron by 3.5% in the 2nd quarter. Elevation Point Wealth Partners LLC now owns 3,398 shares of the scientific and technical instruments company’s stock worth $447,000 after buying an additional 115 shares during the last quarter. 96.19% of the stock is currently owned by hedge funds and other institutional investors.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.